2017
DOI: 10.1007/s12098-017-2292-6
|View full text |Cite
|
Sign up to set email alerts
|

Inflammatory Markers and Disease Activity in Juvenile Idiopathic Arthritis

Abstract: Inflammatory markers and disease activity decreased in all subtypes of JIA with treatment without biologics. Acute phase markers often remain elevated in inactive disease state. Similarly, normal level of an inflammatory marker does not necessarily indicate absence of active disease.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
15
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 14 publications
(16 citation statements)
references
References 16 publications
1
15
0
Order By: Relevance
“…The analysis of the ESR demonstrates the disease activity both at onset and follow-up of the subjects with JIA. In a similar manner, CRP is also an inflammatory parameter, as an acute phase protein [29]. During active disease, high ESR and CRP values relate to immunologic response; particularly innate immun phase.…”
Section: Discussionmentioning
confidence: 92%
“…The analysis of the ESR demonstrates the disease activity both at onset and follow-up of the subjects with JIA. In a similar manner, CRP is also an inflammatory parameter, as an acute phase protein [29]. During active disease, high ESR and CRP values relate to immunologic response; particularly innate immun phase.…”
Section: Discussionmentioning
confidence: 92%
“…Increased levels of these inflammatory cytokines have also been reported in JIA 35 . Measurement of inflammatory activity in JIA is more accurate with JADAS27, 24 and this is probably why we did in fact identify an association based on this instrument but not on the DAS28.…”
Section: Discussionmentioning
confidence: 65%
“…Additional data recorded for patients with JIA included the date of onset of the disease, duration of the disease (time from diagnosis to the cut‐off), diagnostic delay (months between onset of symptoms and diagnosis of JIA), uveitis, and the following laboratory data: rheumatoid factor (RF), positive if >20 IU/mL; anticitrullinated peptide antibodies (ACPA), positive if >10 IU/mL; positive human leukocyte antigen‐B27 titer; and positive antinuclear antibody (ANA) titer at any point during the disease. Disease activity was assessed cross‐sectionally using the following: Disease Activity Score of 28 joints – erythrocyte sedimentation rate (DAS28‐ESR) 23 ; Juvenile Arthritis Disease Activity Score (JADAS27) (based on a 27‐joint count) 24 ; and physical function by means of the Health Assessment Questionnaire (HAQ) 25 . We recorded all current medication, synthetic disease‐modifying antirheumatic drugs (DMARDs), (methotrexate, leflunomide, and sulfasalazine), biologic DMARDs (anti‐TNF inhibitors, tocilizumab, abatacept, rituximab, and ustekinumab), and Janus‐activated kinase inhibitors (tofacitinib and baricitinib).…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations